Bilcare Annual General Meeting
Bilcare Limited issued a corrigendum for its 39th Annual General Meeting, correcting a clerical error where a director's appointment resolution was mislabeled as a special resolution.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Bilcare Limited issued a corrigendum for its 39th Annual General Meeting, correcting a clerical error where a director's appointment resolution was mislabeled as a special resolution.
Non-promoter Guttikonda Anuradha, Vara Lakshmi and Rajasekhar bought 4,73,264 Bilcare shares in the open market, lifting PAC holdings to 16.47%. No transaction price was disclosed.
Bilcare Limited has appointed Mr. Mohan Bhandari and re-appointed Ms. Kavita Bhansali as Executive Directors for a three-year term, effective August 2026.
Bilcare Limited issued the Notice for its 39th Annual General Meeting scheduled for September 26, 2026, to transact six agenda items, including related party transaction approvals.
Non-promoters Guttikonda Anuradha, Vara Lakshmi, and Rajasekhar sold 6,15,180 shares of Bilcare Ltd via open market on August 19, 2026.
Bilcare Limited appointed Mohan Bhandari and Kavita Bhansali as Executive Directors. The company also announced the resignation of Company Secretary Sagar R. Baheti and appointment of Mayur Dave.
Bilcare Ltd reported revenue from operations of ₹225.9 Cr (+21.2% YoY) and net profit of ₹15 Cr for Q1 FY27.
Bilcare Limited has scheduled a board meeting on August 13, 2026, to consider and approve the unaudited standalone and consolidated financial results for the June quarter.
Bilcare Limited has appointed Ashwini Ashok Hasabnis as a Non-Executive Independent Director. The appointment is for a term of 60 months effective from July 22, 2026.
Bilcare Ltd successfully passed the special resolution for the appointment of Mrs. Ashwini Ashok Hasabnis as a Non-Executive Woman Independent Director via postal ballot.
Bilcare Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The report details equity distribution across promoter and public categories.
NCLT Mumbai condoned Bilcare's delay in fixed deposit repayment and directed deposit of Rs. 25.48 Cr into IEPF by July 15, 2026. The order provides legal closure on past defaults and a clear compliance path.
Bilcare Limited opted not to convert 3,15,000 warrants in Caprihans India Limited, leading to their lapse. This results in the forfeiture of a ₹1.58 Crore subscription deposit.
Bilcare Limited submitted its Annual Secretarial Compliance Report for the financial year 2025-2026. The report confirms adherence to SEBI regulations with no material non-compliances noted.
Bilcare Ltd reported revenue from operations of ₹187.7 Cr (-3.2% YoY) and net profit of ₹7.8 Cr (-35.5% YoY) for Q4 FY26.
Bilcare Limited reported audited annual financial results and redeemed ₹15.60 Crore of preference shares. The company also converted 10,40,000 warrants into equity shares.
Bilcare Limited scheduled a board meeting on May 29, 2026, to approve audited financial results. The trading window remains closed until 48 hours post-declaration.
Bilcare Limited informed the Bombay Stock Exchange that it does not fall under the 'Large Corporate' category as per SEBI Circular criteria. The filing confirms the non-applicability of the framework regarding fund raising through debt securities for the company.